ID

12117

Descrizione

Peripheral Endothelial Function Assessment of Patients on Ticagrelor vs. Clopidogrel Who Have Undergone PCI; ODM derived from: https://clinicaltrials.gov/show/NCT02469740

collegamento

https://clinicaltrials.gov/show/NCT02469740

Keywords

versioni (1)
  1. 24/09/15 24/09/15 - Julian Varghese
Caricato su

24 settembre 2015

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Myocardial Ischemia NCT02469740

Inglese

Eligibility Myocardial Ischemia NCT02469740

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
subjects must be able and willing to give written informed consent and to comply with the requirements of this study protocol
Descrizione

able and willing to give written informed consent; study protocol

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021430
subjects must be male or female, aged 18 years or above at baseline
Descrizione

aged 18 years or older; baseline; female

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
diagnosed with coronary artery disease and undergone pci
Descrizione

coronary artery disease; pci

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0010068
UMLS CUI [2]
C1532338
female subjects of child bearing potential must be willing to ensure that they or their partner use effective contraception during the study and for 12 months (as per guidelines on patients undergoing pci who are on antiplatelet therapy).
Descrizione

Childbearing Potential | Contraceptive methods

Tipo di dati

boolean

Alias
UMLS CUI [1]
C3831118
UMLS CUI [2]
C0700589
female subjects' urine pregnancy test performed at the baseline visit must be negative (which is required by local hospital policy in order to undergo pci).
Descrizione

urine pregnancy test

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0430056
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
allergy/hypersensitivity to study medications or their ingredients
Descrizione

allergy/hypersensitivity to study medications or their ingredients

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C3854006
contraindications to either clopidogrel or ticagrelor:
Descrizione

contraindications; clopidogrel; ticagrelor

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0522473
UMLS CUI [1,2]
C0070166
UMLS CUI [2,1]
C0522473
UMLS CUI [2,2]
C1999375
ticagrelor contraindications - active bleeding, history of intracranial haemorrhage, moderate to severe hepatic impairment, dialysis, uric acid nephropathy, co-administration of a strong cyp3a4 inhibitor (e.g. ketoconazole, clarithromycin, nefazodone, ritonavir and atazanavir), history of sick sinus syndrome or high degree av block without pacemaker protection
Descrizione

Hemorrhage | Intracranial Hemorrhages | Hepatic impairment | Dialysis procedure | Urate nephropathy | Cytochrome P450 3A4 Inhibitor | Sick Sinus Syndrome | AV BLOCK HIGH DEGREE

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0019080
UMLS CUI [2]
C0151699
UMLS CUI [3]
C0948807
UMLS CUI [4]
C0011946
UMLS CUI [5]
C2955673
UMLS CUI [6]
C3830624
UMLS CUI [7]
C0037052
UMLS CUI [8]
C0741311
clopidogrel contraindications - severe hepatic impairment, active bleeding
Descrizione

contraindications; active bleeding; clopidogrel; impairment; hepatic; severe

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0019080
UMLS CUI [2]
C0948807
on treatment with oral anticoagulant (vitamin k antagonist, dabigatran, rivaroxaban, apixaban)
Descrizione

Anticoagulants, Oral

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0354604
unable to follow up in research centre (for example, due to logistic difficulties)
Descrizione

unable to follow up in research centre

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1522577
UMLS CUI [1,2]
C1321605
female subjects who are pregnant or breast-feeding, or considering becoming pregnant during the study.
Descrizione

female subjects who are pregnant or breastfeeding.; female subjects who are pregnant or nursing; breast-feeding; study

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0549206
UMLS CUI [2]
C0006147
UMLS CUI [3]
C2081645
subjects who have participated in another study and received any other investigational agent within the previous 12 months
Descrizione

subjects who have participated in another study and received any other investigational agent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2348568
subjects unable to provide written informed consent within 24 hours of pci (for example, intubated patients)
Descrizione

inability to provide written informed consent; able to provide written informed consent; pci

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021430
subjects who have a history of drug or alcohol use that, in the opinion of the investigator, would interfere with adherence to study requirements.
Descrizione

alcohol drug abuse

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0740858
use of both left and right radial access for pci
Descrizione

use of both left and right radial access for pci

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1532338
UMLS CUI [1,2]
C3272298
Ritorna all'inizio della pagina

Similar models

Eligibility Myocardial Ischemia NCT02469740

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
able and willing to give written informed consent; study protocol
Item
subjects must be able and willing to give written informed consent and to comply with the requirements of this study protocol
boolean
C0021430 (UMLS CUI [1])
aged 18 years or older; baseline; female
Item
subjects must be male or female, aged 18 years or above at baseline
boolean
C0001779 (UMLS CUI [1])
coronary artery disease; pci
Item
diagnosed with coronary artery disease and undergone pci
boolean
C0010068 (UMLS CUI [1])
C1532338 (UMLS CUI [2])
Childbearing Potential | Contraceptive methods
Item
female subjects of child bearing potential must be willing to ensure that they or their partner use effective contraception during the study and for 12 months (as per guidelines on patients undergoing pci who are on antiplatelet therapy).
boolean
C3831118 (UMLS CUI [1])
C0700589 (UMLS CUI [2])
urine pregnancy test
Item
female subjects' urine pregnancy test performed at the baseline visit must be negative (which is required by local hospital policy in order to undergo pci).
boolean
C0430056 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
allergy/hypersensitivity to study medications or their ingredients
Item
allergy/hypersensitivity to study medications or their ingredients
boolean
C0020517 (UMLS CUI [1,1])
C3854006 (UMLS CUI [1,2])
contraindications; clopidogrel; ticagrelor
Item
contraindications to either clopidogrel or ticagrelor:
boolean
C0522473 (UMLS CUI [1,1])
C0070166 (UMLS CUI [1,2])
C0522473 (UMLS CUI [2,1])
C1999375 (UMLS CUI [2,2])
Hemorrhage | Intracranial Hemorrhages | Hepatic impairment | Dialysis procedure | Urate nephropathy | Cytochrome P450 3A4 Inhibitor | Sick Sinus Syndrome | AV BLOCK HIGH DEGREE
Item
ticagrelor contraindications - active bleeding, history of intracranial haemorrhage, moderate to severe hepatic impairment, dialysis, uric acid nephropathy, co-administration of a strong cyp3a4 inhibitor (e.g. ketoconazole, clarithromycin, nefazodone, ritonavir and atazanavir), history of sick sinus syndrome or high degree av block without pacemaker protection
boolean
C0019080 (UMLS CUI [1])
C0151699 (UMLS CUI [2])
C0948807 (UMLS CUI [3])
C0011946 (UMLS CUI [4])
C2955673 (UMLS CUI [5])
C3830624 (UMLS CUI [6])
C0037052 (UMLS CUI [7])
C0741311 (UMLS CUI [8])
contraindications; active bleeding; clopidogrel; impairment; hepatic; severe
Item
clopidogrel contraindications - severe hepatic impairment, active bleeding
boolean
C0019080 (UMLS CUI [1])
C0948807 (UMLS CUI [2])
Anticoagulants, Oral
Item
on treatment with oral anticoagulant (vitamin k antagonist, dabigatran, rivaroxaban, apixaban)
boolean
C0354604 (UMLS CUI [1])
unable to follow up in research centre
Item
unable to follow up in research centre (for example, due to logistic difficulties)
boolean
C1522577 (UMLS CUI [1,1])
C1321605 (UMLS CUI [1,2])
female subjects who are pregnant or breastfeeding.; female subjects who are pregnant or nursing; breast-feeding; study
Item
female subjects who are pregnant or breast-feeding, or considering becoming pregnant during the study.
boolean
C0549206 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C2081645 (UMLS CUI [3])
subjects who have participated in another study and received any other investigational agent
Item
subjects who have participated in another study and received any other investigational agent within the previous 12 months
boolean
C2348568 (UMLS CUI [1])
inability to provide written informed consent; able to provide written informed consent; pci
Item
subjects unable to provide written informed consent within 24 hours of pci (for example, intubated patients)
boolean
C0021430 (UMLS CUI [1])
alcohol drug abuse
Item
subjects who have a history of drug or alcohol use that, in the opinion of the investigator, would interfere with adherence to study requirements.
boolean
C0740858 (UMLS CUI [1])
use of both left and right radial access for pci
Item
use of both left and right radial access for pci
boolean
C1532338 (UMLS CUI [1,1])
C3272298 (UMLS CUI [1,2])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial